Ann: Clinical Trial Contract Expansion & Increases with Bayer AG, page-3

  1. 416 Posts.
    lightbulb Created with Sketch. 150
    I dont think the revenue is that important but the below statement.


    This further contract amendment and expansion with Bayer continues to validate the
    unique capabilities of our FDA-cleared SphygmoCor® technology. Importantly, it is this
    technology - that is trusted by the leading global pharmaceutical companies - that
    forms the basis of our competitive differentiation as we expand into wearables, smart
    home health devices and other new markets”.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.8¢
Change
-0.003(7.32%)
Mkt cap ! $20.90M
Open High Low Value Volume
3.8¢ 3.8¢ 3.7¢ $33.87K 903.9K

Buyers (Bids)

No. Vol. Price($)
1 36009 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 500000 1
View Market Depth
Last trade - 15.40pm 25/07/2025 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.